Glioblastomas are one of the most malignant and lethal cancers. Despite recent treatment advancements, median survival is only 12 to 16 months. In 2015, the Optune device, a novel, non-invasive ...
DOI: 10.1200/JCO.2016.34.15_suppl.e14570 Journal of Clinical Oncology 34, no. 15_suppl ...
Tokyo, Japan – Researchers from Tokyo Metropolitan University have created a new way of telling “aged” human cells apart from younger ones using electric fields. While key markers have been found for ...
Novocure GmbH secured U.S. FDA approval for Optune Lua, a wearable device that delivers alternating electric fields or tumor treating fields that kill cancer cells. Indicated for use with PD-1/PD-L1 ...
Researchers from Tokyo Metropolitan University have created a new way of telling "aged" human cells apart from younger ones using electric fields. While key markers have been found for these ...
Radio Frequency Company's Macrowave radio frequency pasteurization systems have been fully validated to treat rice flour used ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results